Entelos pays up to $39M for Iconix Biosciences
In a rare all-Bay Area biotech transaction, Foster City, Calif.’s Entelos agreed to acquire Iconix Biosciences for up to $39.1 million in stock. See our story in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Mogad gets half a million to build a better recommendation site
Previous Story: Latest action: Seatsmart, Hulu, Sonsini’s suit, San Jose’s riches & more
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.